Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.
This study is currently recruiting participants.
Verified February 2013 by GlaxoSmithKline
Study NCT01248858
Information provided by GlaxoSmithKline
First Received on November 18, 2010.
Last Updated on February 28, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: